Skip to main content

Allergan, Inc. (NYSE:AGN) Investor Investigation Over Potential Wrongdoing In Takeover

  • If you purchased shares of Allergan, Inc. (NYSE:AGN) and currently hold any of those NYSE:AGN shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

October 27, 2014 (Update) - On May 28, 2014, Allergan, Inc confirmed that it has received a revised, unsolicited proposal from Valeant Pharmaceuticals International, Inc. to acquire all of the outstanding shares of Allergan, Inc for a combination of 0.83 of Valeant Pharmaceuticals International common shares,$58.30 in cash per share of common stock of the Company, and a Contingent Val...



You must register (for free) or login to view the entire investigation.